Safety and Pharmacokinetic Characteristics of DP-R202 in Healthy Male Volunteers

NCT01421563 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Anplag

Sponsor

Alvogen Korea